Ibotta Vs. NovoCure Industry Stock Comparison

Buy

84

IBTA
Ibotta

Last Price:

72.80

Seasonality Move:

--

Buy

77

NVCR
NovoCure

Last Price:

29.28

Seasonality Move:

2.04%

Buy

84

Ibotta (IBTA) is a Buy

Is Ibotta a Buy, Sell or Hold?

The current Ibotta [IBTA] share price is $72.72. The Score for IBTA is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
IBTA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

Buy

77

NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IBTA Stock Price Chart

What is Ibotta's stock price today?

The Ibotta share price today is $72.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBTA is experiencing selling pressure, which indicates risk of future bearish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

The NovoCure share price today is $30.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

IBTA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.76	Buy
Relative Strength Index (14 RSI):	54.97	Buy
Chaikin Money Flow:	-192687	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(67.55 - 75.27)	Buy
Bollinger Bands (100):	(55.71 - 71.67)	Buy

NVCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.24	Buy
Relative Strength Index (14 RSI):	84.56	Buy
Chaikin Money Flow:	-690353	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(14.69 - 22.01)	Buy
Bollinger Bands (100):	(15.44 - 20.28)	Buy

IBTA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	71.24	Buy
20-day SMA:	70.68	Buy
50-day SMA:	68.8	Buy
200-day SMA:	0	Buy
8-day EMA:	71.56	Buy
20-day EMA:	70.66	Buy
50-day EMA:	68.85	Buy
200-day EMA:	20.03	Buy

NVCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	21.45	Buy
20-day SMA:	18.85	Buy
50-day SMA:	17.12	Buy
200-day SMA:	17.34	Buy
8-day EMA:	23.1	Buy
20-day EMA:	19.92	Buy
50-day EMA:	18.23	Buy
200-day EMA:	19.07	Buy

Ibotta Earnings Growth & IBTA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

Ibotta Technical Analysis

	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29	Dec 2	Dec 3
	Nov									Dec
	19	20	21	22	25	26	27	29	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29	Dec 2	Dec 3
	Nov									Dec
	19	20	21	22	25	26	27	29	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):